COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,551 Articles (22,881 medRxiv, 8,670 bioRxiv)

Most recent first Previous |  Page 2893: Articles 28921-28930  | Next

PSGL-1 blocks SARS-CoV-2 S protein-mediated virus attachment and infection of target cells
He, S., Hetrick, B., Dabbagh, D., Akhrymuk, I. V., Kehn-Hall, K., Freed, E. O., Wu, Y.
10.1101/2020.05.01.073387 — Posted: 2020-05-02
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps
Blanco-Miguez, A., Sanchez, B.
10.1101/2020.05.02.072439 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Functional pathways in respiratory tract microbiome separate COVID-19 from community-acquired pneumonia patients
Haiminen, N., Utro, F., PARIDA, L.
10.1101/2020.05.01.073171 — Posted: 2020-05-02
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N., Yang, X., Chen, S., Zhao, G., Wang, X., Luo, D., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Shi, B., Sun, S., Qin, C.-F., Zhou, Y.
10.1101/2020.05.02.073411 — Posted: 2020-05-02 Discussion: Onsite
Identification of Drugs Blocking SARS-CoV-2 Infection using Human Pluripotent Stem Cell-derived Colonic Organoids
Duan, X., Han, Y., Yang, L., Nilsson, B., Wang, P., Zhang, T., Wang, X., Xu, D., Xiang, J. Z., uhl, s., Huang, Y., Chen, H., Wang, H., tenOever, B. R., Schwartz, R. E., Ho, D. D., Pan, F. C., Chen, S., Evans, T. R.
10.1101/2020.05.02.073320 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
Shajahan, A., Archer-hartmann, S. A., Supekar, N. T., Gleinich, A. S., Heiss, C., Azadi, P.
10.1101/2020.05.01.071688 — Posted: 2020-05-02 Discussion: Onsite
Performance verification of detecting COVID-19 specific antibody by using four chemiluminescence immunoassay systems
Wan, Y., Li, Z., Wang, K., Li, T., Liao, P.
10.1101/2020.04.27.20074849 — Posted: 2020-05-02
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
Gomes, M. G. M., Aguas, R., Corder, R. M., King, J. G., Langwig, K. E., Souto-Maior, C., Carneiro, J., Ferreira, M. U., Penha-Goncalves, C.
10.1101/2020.04.27.20081893 — Posted: 2020-05-02 Discussion: Onsite | Offsite
Control with uncertain data of socially structured compartmental epidemic models
Albi, G., Pareschi, L., Zanella, M.
10.1101/2020.04.27.20081885 — Posted: 2020-05-02
Ecologic correlation between underlying population level morbidities and COVID-19 case fatality rate among countries infected with SARS-CoV-2
OKPOKORO, E., IGBINOMWANHIA, V., JEDY-AGBA, E., KAYODE, G., ONYEMATA, E., ABIMIKU, A.
10.1101/2020.04.28.20082370 — Posted: 2020-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).